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Abstract 
The objective of this study was to investigate the influence of dynamic compressive 
loading on chondrogenesis of mesenchymal stem cells (MSCs) in the presence of 
TGF-β3. Isolated porcine MSCs were suspended in 2% agarose and subjected to 
intermittent dynamic compression (10% strain) for a period of 42 days in a dynamic 
compression bioreactor. After 42 days in culture, the free-swelling specimens 
exhibited more intense alcian blue staining for proteoglycans, while 
immunohistochemical analysis revealed increased collagen type II immunoreactivity. 
Glycosaminoglycan (GAG) content increased with time for both free-swelling and 
dynamically loaded constructs, and by day 42 it was significantly higher in both the 
core (2.5±0.21 %w/w vs. 0.94±0.03 %w/w) and annulus (1.09±0.09 %w/w vs. 
0.59±0.08 %w/w) of free-swelling constructs compared to dynamically loaded 
constructs. This result suggests that further optimization is required in controlling the 
biomechanical and/or the biochemical environment if such stimuli are to have 
beneficial effects in generating functional cartilaginous tissue. 
 
Keywords: Chondrogenesis; Mesenchymal stem cells; TGF-β3; Dynamic 
compression; Tissue engineering. 
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Introduction 
Articular cartilage has a limited capacity for repair. This has motivated the 
development of cell based therapies such as autologous chondrocyte implantation for 
the repair of cartilage defects [1; 2]. A major limiting factor in extending the use of 
such therapies is obtaining sufficient numbers of differentiated autologous 
chondrocytes, particularly in elderly and more osteoarthritic (OA) patients. An age-
related loss in chondrogenic capacity has been observed in culture-expanded 
chondrocytes [3], while collagen synthesis is lower in chondrocytes obtained from 
OA patients [4]. This may be partially explained by changes in the responsiveness of 
aged or OA chondrocytes to cytokines and growth factors [5-7]. In addition, OA 
chondrocytes are likely to have significant DNA damage among other cellular 
degenerative alterations [8].  
Mesenchymal stem cells (MSCs) are a promising alternative cell source for 
cartilage repair due to both their ease of isolation and expansion, and their 
chondrogenic differentiation potential [9]. Chondrogenic differentiation of MSCs 
from different tissue sources has been demonstrated in the presence of growth factors 
from the transforming growth factor-β (TGF- β) superfamily [10-15]. A tissue 
engineering approach to repair damaged cartilage tissues would involve seeding 
MSCs into a scaffold and either implanting following minimal in vitro pre-culture, or 
to culture these constructs for longer periods of time to engineer a more functional 
cartilaginous tissue. While chondrogenesis does occur in these different systems, it 
has been demonstrated that the amount of cartilage matrix production and the 
subsequent mechanical properties of the tissue is lower with MSCs compared to 
chondrocytes [16], leading to the suggestion that further optimization may be required 
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if MSCs are to be used to engineer cartilaginous tissues with similar functional 
properties to that obtainable with healthy chondrocytes.  
It is well established that the application of appropriate levels of dynamic 
compressive loading can enhance the biosynthetic activity of chondrocytes [17-23]. It 
is also believed that the differentiation pathway of MSCs is at least partially regulated 
by the local mechanical environment. In the absence of chondrogenic growth factors, 
it has been demonstrated that dynamic compressive loading can enhance 
chondrogenesis of bone marrow derived MSCs [24-26]. For example, increased 
aggrecan gene expression has been observed with as few as three 4 hour loading 
cycles [25], however other studies have observed little dynamic compression induced 
stimulation of gene expression or matrix synthesis in the absence of chondrogenic 
growth factors [27]. However, the combined effects of dynamic compression and 
chondrogenic growth factors (TGF-β) on chondrogenesis of MSCs are generally more 
complex [24; 27]. Dynamic compression has been shown to up-regulate aggrecan 
gene expression in the absence of TGF-β, but to down-regulate it in the presence of 
TGF-β [24]. In both the presence and absence of chondrogenic growth factors, it has 
been demonstrated that short-term exposure (≤ 1 week) to intermittent dynamic 
compression leads to enhanced GAG synthesis in the proceeding weeks of culture 
compared to free swelling controls [26; 28]. What remains unclear is what influence 
long-term application of dynamic compression has on the differentiation of MSCs in a 
chondrogenic environment. This is an important question not only for engineering 
functional cartilaginous tissues from MSCs, but also to understand how MSCs will 
respond once implanted into load bearing defects. The goal of this study was to 
determine how the daily application of dynamic compressive loading influences 
cartilage specific matrix production by MSCs undergoing chondrogenic 
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differentiation in long-term agarose culture. Our initial hypothesis was that dynamic 
compression would enhance matrix synthesis, leading to increases in the mechanical 
properties of MSC seeded agarose hydrogels.  
 
Methods  
Cell isolation, expansion and agarose hydrogel encapsulation 
Femora from a 4 month old porcine donor (~50 kg) were sawn and the gelatinous 
bone marrow removed under sterile conditions. Porcine MSCs were isolated and 
expanded according to a modified method developed for human MSCs [29]. Cultures 
were expanded in high-glucose Dulbecco’s Modified Eagle Medium (DMEM 
GlutaMAX) supplemented with 10% foetal bovine serum (FBS), and penicillin (100 
U/mL)-streptomycin (100 μg/mL) (all GIBCO, Biosciences, Ireland). Culture-
expanded MSCs (3rd passage) were encapsulated in agarose (Type VII) at ~40°C, to 
yield a final gel concentration of 2% and a cell density of 15×106 cells/mL. The 
agarose-cell suspension was cast in a stainless steel mould to produce cylindrical discs 
(Ø 6mm×4mm thickness). Constructs were maintained in a chemically defined 
chondrogenic medium (CM) consisting of DMEM GlutaMAX supplemented with 
penicillin (100 U/mL)-streptomycin (100 μg/mL) (both GIBCO, Biosciences, 
Ireland), 100 μg/ml sodium pyruvate, 40 μg/ml L-proline, 50 μg/ml L-ascorbic acid-2-
phosphate, 1 mg/ml BSA, 1× insulin–transferrin–selenium, 100 nM dexamethasone 
(all from Sigma-Aldrich, Ireland) and 10 ng/ml recombinant human transforming 
growth factor-β3 (TGF-β3; R&D Systems, UK). Constructs were allowed to 
equilibrate for 4 days before the addition of dexamethasone and TGF-β3, and the 
initiation of mechanical compressive loading. 
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Application of dynamic compression 
Intermittent dynamic compression (DC) was carried out in a custom pneumatic based 
compressive loading bioreactor with the constructs immersed in CM. The dynamic 
compression protocol consisted of ~10% strain amplitude superimposed on a 0.01 N 
preload at a frequency of 0.5 Hz. This loading regime was employed for a period of 1 
hour, 5 days/week. Free swelling (FS) controls were maintained in the same amount 
of medium adjacent to the loading device during loading periods. A 50% medium 
exchange was performed every 2-3 days.  
 
Mechanical and biochemical analysis 
Constructs were mechanically tested in unconfined compression between 
impermeable platens using a standard materials testing machine with a 5N load cell 
(Zwick Z005, Roell, Germany). Stress relaxation tests were performed, consisting of a 
ramp and hold cycle with a ramp displacement of 1 μm/s until 10% strain was 
obtained and maintained until equilibrium was reached (~30 minutes). Dynamic tests 
were performed immediately after the stress relaxation cycle. A cyclic strain 
amplitude of 1% superimposed upon the 10% strain was applied for 10 cycles at 1Hz. 
The compressive equilibrium modulus and dynamic modulus were determined from 
these tests. 
The biochemical content of constructs was assessed at each time point (0, 14 
and 42 days); constructs were cored using a 3mm biopsy punch, the wet mass of both 
annulus and core was recorded and then frozen for subsequent analyses. Annuli and 
core samples were digested with papain (125µg/ml) in 0.1 M sodium acetate, 5 mM 
L-cysteine HCl, 0.05 M EDTA, pH 6.0 (all from Sigma–Aldrich, Ireland) at 60°C 
under constant rotation for 18hours. DNA content was quantified using the Hoechst 
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Bisbenzimide 33258 dye assay as described previously [30], with a calf thymus DNA 
standard. Proteoglycan content was estimated by quantifying the amount of sulphated 
glycosaminoglycan (GAG) in constructs using the dimethylmethylene blue dye-
binding assay (Blyscan, Biocolor Ltd., Northern Ireland), with a chondroitin sulphate 
standard. Total collagen content was determined by measuring the hydroxyproline 
content [31], using a hydroxyproline-to-collagen ratio of 1:7.69 [32]. 
 
Histology and immunohistochemistry 
At each time point, at least one sample per group was fixed in 4% paraformaldehyde 
overnight, rinsed in PBS, and embedded in paraffin. The constructs were embedded 
such that sectioning at 8 μm produced a cross section perpendicular to the disc face. 
Sections were stained with 1% alcian blue 8GX (Sigma–Aldrich, Ireland) in 0.1M 
HCl which stains sGAG, and picro-sirius red to stain collagen. The deposition of 
collagen type II was indentified by immunohistochemical analysis. A rabbit anti-
human polyclonal antibody (concentration 3 g/L; MD Biosciences, Switzerland) that 
binds to collagen type II was used. The presence of the collagen type II antibody was 
subsequently detected by the secondary antibody, biotin-labelled goat anti-rabbit 
polyclonal (concentration 1 g/L; Sigma–Aldrich, Ireland). Negative and positive 
controls, trachea and cartilage respectively, were included.  
 
Statistical Analysis 
Statistical analyses were preformed using GraphPad Prism (Version 4.03) software 
with 3-4 samples analysed for each experimental group. Two-way ANOVA was used 
for analysis of variance with Bonferroni post-tests to compare between groups. 
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Numerical and graphical results are displayed as mean ± standard deviation. 
Significance was accepted at a level of p < 0.05. 
 
Results 
There were no statistical differences in the DNA content between the FS and DC 
groups at any time point; or between core and annular regions within any group of 
constructs (Fig. 1A). 
 The GAG content was significantly higher after both 14 and 42 days in culture 
compared to the corresponding samples on day 0 (Fig. 1B). No difference was found 
between the FS and DC groups for annulus and core respectively at day 14. However 
at day 42, both annulus (1.09±0.09 %w/w vs. 0.59±0.08 %w/w) and core (2.5±0.21 
%w/w vs. 0.94±0.03 %w/w) regions for FS constructs were significantly greater 
(p<0.001) than DC constructs. GAG content in the core region of all construct groups 
was significantly greater than that in the annulus (Fig. 1B). Collagen content was also 
higher in FS constructs compared to DC constructs at day 42 (Fig. 1C). 
 Staining of construct sections with alcian blue for sulphated proteoglycan 
revealed a steady accretion of positive staining for both FS and DC conditions (Fig. 
2). At both days 14 and 42 the FS constructs exhibited more intense positive staining 
for GAG than the DC constructs. Similar trends were seen in the Picro-sirius staining 
for collagen (data not shown). This staining corresponded to biochemical results, with 
a less intense staining around the periphery of the construct. The collagen type II 
immunohistochemistry (Fig. 2) provides evidence of chondrogenic differentiation, 
again showing stronger staining away from the construct edge. The DC constructs 
exhibit a more homogeneous spatial staining in each case than the FS constructs. 
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 The equilibrium and dynamic mechanical properties were dependent on time 
in culture (p<0.001) and mechanical stimulation (p<0.001) (Fig.3). However, 
significant differences between FS and DC were only seen at day 42 (p<0.001); the 
equilibrium modulus of day 42 FS constructs reached 49.9±0.6 kPa compared to 
24.4±1.5 kPa for the DC constructs. The 1 Hz dynamic modulus followed a similar 
trend with day 42 FS constructs reaching 230.7±3.4 kPa compared to 111.4±4.1 kPa 
for the DC constructs. Notably, the mechanical properties of DC constructs did not 
increase between day 14 and 42. 
 
Discussion 
Whether injected directly in-vivo, or cultured ex-vivo on scaffolds prior to 
implantation, understanding the response of MSCs to physical forces is of critical 
importance when developing cell based therapies for cartilage repair. Our hypothesis 
was that intermittent dynamic compression applied daily to MSCs in agarose culture 
in a chemically defined medium supplemented with TGF-β3 would enhance 
chondrogenesis, resulting in the formation of a more functional cartilaginous tissue. 
No evidence was found to support this hypothesis. Rather dynamic compressive 
loading was observed to inhibit chondrogenesis of MSCs in the presence of TGF-β3.  
There are a number of factors that could explain the observed results. Our 
initial hypothesis was based on the observation that dynamic compressive loading of 
chondrocytes in agarose culture stimulates cartilage specific gene expression and 
protein synthesis [20; 23]. In this study, dynamic compressive loading was applied 
shortly after the MSCs had been exposed to chondrogenic growth factors. At this 
early stage in the differentiation process, it is perhaps not surprising that MSCs do not 
respond to biophysical stimulation in a similar manner to fully differentiated articular 
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chondrocytes. Mouw et al. [27] observed that the response of bone marrow derived 
MSCs in agarose culture to dynamic compression varied during the process of 
chondrogenesis, with dynamic compression only enhancing chondrogenesis following 
16 days of pre-culture in free swelling conditions in the presence of TGF-β1. It was 
suggested that the developing pericellular and extracellular matrix may be regulating 
mechano-stimulation of MSCs undergoing chondrogenesis. Cartilage matrix synthesis 
by articular chondrocytes in dynamically compressed agarose gels is greater at later 
time points than earlier time points [20], implying that a well developed matrix may 
be required for the transduction of mechanical compression to a cellular biosynthetic 
response. 
Another possible explanation is that the type, magnitude, frequency or 
duration of the applied mechanical stimulus in this study (unconfined compression at 
10% strain at 0.5Hz for 1 hour/day) inhibits chondrogenesis of MSCs. The application 
of this loading protocol produces a complex mechanical environment within the 
agarose hydrogel, with magnitudes of deformation, hydrostatic pressure and fluid 
velocities that vary spatially and temporally. Theoretical models have suggested that 
the mechanical environment can regulate the differentiation pathway of MSCs [33; 
34], and it is possible that excessive levels of deformation or fluid flow in the agarose 
hydrogel, particularly in the absence of a fully developed pericellular matrix to 
regulate mechano-transduction, could be promoting the formation of a more 
fibroblastic phenotype. Immunohistochemical analysis also revealed the presence of 
type I collagen in both FS and DC constructs (data not shown). Comparisons of 
different bioreactor systems for cartilage tissue engineering suggest that fluid flow 
plays a role in regulating chondrogenesis [35]. Chondrocyte differentiation has also 
been shown to be modulated by the frequency and duration of cyclic compressive 
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loading [36]. Altering parameters of the dynamic compression loading protocol such 
as the strain magnitude and frequency would allow this hypothesis to be investigated 
further.   
These factors do not explain the results of similar studies where mechanical 
loading in the absence of TGF-β enhances chondrogenesis [24-26], even when 
applied shortly after agarose encapsulation. This would suggest that a more complex 
interplay exists between the biophysical and biochemical environment in regulating 
chondrogenesis of MSCs, leading to the inhibition of cartilage-specific matrix 
production observed in this study. There are many potential interactions that need to 
be considered. In free swelling cultures, it was observed that total GAG synthesis was 
greater in the core compared to the annulus of the agarose hydrogels (Fig. 1).  This 
may be partially explained by diffusion of GAGs from the annulus of the construct 
into the surrounding media. Anther explanation may be diffusion limitations or cell 
consumption at the periphery of the hydrogel producing a radial gradient in the 
molecules responsible for regulating chondrogenesis. For example, lower 
concentrations of TGF-β3 or oxygen towards the core may be promoting 
chondrogenesis. If this is the case, the enhanced transport and concentration of these 
molecules due to dynamic compression [37] may explain the inhibition of 
chondrogenesis in this study. For example, hypoxia has been shown to promote 
chondrogenesis of MSCs in the presence of chondrogenic growth factors [38], 
however it has also been shown that diffusional limitations in oxygen supply can 
result in more anaerobic conditions resulting in markedly reduced rates in the growth 
of chondrocyte seeded polymer scaffolds [39]. The biosynthetic response of cartilage 
explants to TGF-β treatment has been shown to be dose dependant, reaching 
saturation at 10ng/ml [40]. Chondrogenic differentiation of MSCs would also appear 
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to depend on the dose of TGF-β, with 5ng/ml of TGF-β1 reported as optimal in 
monolayer culture [41]. In pellet culture it has been reported that at a concentration of 
1ng/ml of TGF-β1, chondrogenesis is limited to the outer third of the cell aggregate, 
with more homogenous chondrogenesis at 10ng/ml [11]. In addition, stimulation of 
the TGF-β signalling pathway could modulate mechano-transduction, or alternatively, 
mechanical stimulation may modulate TGF-β signalling [27]. Interestingly, dynamic 
compressive loading of chondrocyte seeded agarose hydrogels applied concurrently 
with exposure to 10 ng/ml of TGF-β3 has also been shown to inhibit GAG synthesis 
[42]. In the same study [42], deformational loading initiated after culturing for two 
weeks in the presence of TGF-β3 yielded significantly stiffer constructs than free–
swelling controls. Adopting a similar loading protocol with MSCs undergoing 
chondrogenesis may produce a more anabolic response to dynamic deformational 
loading. The results of these studies have important implications for post-operative 
rehabilitation regimes following cell-based therapies to repair cartilage, and for 
designing scaffolds to control the biochemical and biophysical environment of MSCs 
following implantation. 
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Figure Legends 
 
Fig. 1. Biochemical composition of both core and annular regions for FS and DC 
groups; (A): DNA content (ng DNA/mg construct w/w), (B): GAG content (% 
construct w/w), (C): Collagen content (% construct w/w). *p<0.05, **p<0.01, 
***p<0.001. ! indicates significant difference (p<0.001) between FS and DC 
constructs (both core and annulus). 
 
 
Fig. 2. Representative alcian blue staining (top) and collagen type II 
immunohistochemistry (bottom) at day 0 and day 42 for both FS and DC construct 
groups. Scale bar: 1 mm. 
 
 
Fig. 3. Equilibrium compressive modulus (left) and 1 Hz dynamic modulus (right) of 
both FS and DC groups at each time point. ***p<0.001. 
 
 
 
Fig. 1. Biochemical composition of both core and annular regions for FS and DC groups; (A): 
DNA content (ng DNA/mg construct w/w), (B): GAG content (% construct w/w), (C): GAG 
content normalised to DNA (μg/ μg). *p<0.05, **p<0.01, ***p<0.001. 
 
 
Fig. 2. Representative alcian blue staining (top) and collagen type II immunohistochemistry 
(bottom) at day 0 and day 42 for both FS and DC construct groups. Scale bar: 1 mm. 
 
 
Fig. 3. Equilibrium compressive modulus (left) and 1 Hz dynamic modulus (right) of both FS 
and DC groups at each time point. ***p<0.001. 
 
